0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint | 
Euan A. Ashley, MRCP, DPhil
JAMA. 2015;313(21):2119-2120. doi:10.1001/jama.2015.3595.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2015;313(21):2114. doi:10.1001/jama.2015.5670.

Viewpoint | 
Xiaoliang Sunney Xie, PhD
JAMA. 2015;313(20):2021-2022. doi:10.1001/jama.2015.5533.

Viewpoint | 
Robert P. Perrillo, MD; Paul Martin, MD; Anna S. Lok, MD
JAMA. 2015;313(16):1617-1618. doi:10.1001/jama.2015.2571.

Viewpoint | 
Kitchener D. Wilson, MD, PhD; Joseph C. Wu, MD, PhD
JAMA. 2015;313(16):1613-1614. doi:10.1001/jama.2015.1846.

Medical News & Perspectives | 
Rita Rubin, MA
JAMA. 2015;313(11):1089-1091. doi:10.1001/jama.2015.0957.

Editorial | 
Howard L. McLeod, PharmD
JAMA. 2015;313(8):803-804. doi:10.1001/jama.2015.1086.

Viewpoint | 
Jennifer A. Doudna, PhD
JAMA. 2015;313(8):791-792. doi:10.1001/jama.2015.287.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;312(1):19. doi:10.1001/jama.2014.7647.

Original Investigation |  FREE
Andrew X. Zhu, MD, PhD; Masatoshi Kudo, MD, PhD; Eric Assenat, MD, PhD; et al.
JAMA. 2014;312(1):57-67. doi:10.1001/jama.2014.7189.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Internal Medicine
Original Investigation  | 
The Strength of Association Between Surrogate End Points and Survival in Oncology A Systematic Review of Trial-Level Meta-analyses
Vinay Prasad, MD, MPH; Chul Kim, MD, MPH; Mauricio Burotto, MD; et al.
JAMA Oncology
JAMA Oncology Clinical Challenge  | 
Melanoma and a Headache
Douglas B. Johnson, MD, MSCI; Tejaswi V. Mudigonda, BS; Jeffrey A. Sosman, MD
JAMA Dermatology
Original Investigation  | 
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Martina Sanlorenzo, MD; Igor Vujic, MD; Adil Daud, MD; et al.
JAMA Oncology
Invited Commentary  | 
Chemotherapy Near the End of Life First—and Third and Fourth (Line)—Do No Harm
Charles D. Blanke, MD; Erik K. Fromme, MD